M0821

Moexipril -hydrochlorid

powder, ≥98% (HPLC)

• Synonym(e): (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid -hydrochlorid
• Empirische Formel (Hill-System): C₂₇H₃₅N₂O₇Cl
• CAS-Nummer: 82586-52-5
• Molekulargewicht: 535.03
• MDL-Nummer: MFCD00940481
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329817832
• NACRES: NA.77

Eigenschaften

• Assay: ≥98% (HPLC)
• Form: powder
• Löslichkeit: H₂O: 32 mg/mL
• Ersteller: UCB Inc.
• Lagertemp.: 2-8°C
• SMILES String: Cl.CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(O)=O
• InChI: 1S/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22-;/m0./s1
• InChIKey: JXRAXHBVZQZSIC-JKVLGAQCSA-N
• Angaben zum Gen: human ... ACE(1636)

Beschreibung

Biochem./physiol. Wirkung

Moexipril is an ACE-Inhibitor; Antihypertensive; Unlike other ACE inhibitors, prolongs QT interval leading to torsades de pointes and cardiad arrhythmia;

Leistungsmerkmale und Vorteile

This compound is featured on the Angiotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by UCB Inc.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS09
• Signalwort: Warning
• H-Sätze: H400
• P-Sätze: P273 - P391 - P501
• Gefahreneinstufungen: Aquatic Acute 1
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves